Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01319110 · ClinicalTrials.gov registry record · Phase 2
Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation
A Phase 2 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT01319110 is a Phase 2 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT01319110, a Phase 2 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
Specific Aim #1: To determine if levels of CoQ10 are low post-cardiac arrest (CA). We will perform a prospective trial with the primary endpoint of describing the prevalence of low serum CoQ10 levels. Specific Aim #2: To determine if CoQ10 levels in post-CA patients can be increased with the administration of exogenous CoQ10.. We will perform a randomized control trial (RCT) of post-CA patients with the secondary endpoint of comparing CoQ10 levels among those randomized to CoQ10 supplementation vs placebo.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DRUG Coenzyme Q10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01319110
The ClinicalTrials.gov registry entry for NCT01319110 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01319110 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01319110 about?
NCT01319110 is a clinical study titled "Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation". Specific Aim #1: To determine if levels of CoQ10 are low post-cardiac arrest (CA). We will perform a prospective trial with the primary endpoint of describing the prevalence of low serum CoQ10 levels. Specific Aim #2: To determine if CoQ10 levels in post-CA patients can be increased with the admini...
What is the current status of trial NCT01319110?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2011-02. Estimated completion is 2011-12-31.
What interventions are being tested in trial NCT01319110?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Coenzyme Q10 (DRUG).
Who is sponsoring clinical trial NCT01319110?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.